Global /Taiwan /Healthcare /Biotechnology /6848
chevron_leftBack
RBC Bioscience Corp. logo

RBC Bioscience Corp.

6848
TPEX: 6848 Delayed
19.45TWD -0.8%
0.6147 USD
As of 20 June 2026, RBC Bioscience Corp. has a market cap of $8.04M USD, ranking #42413 globally and #2335 in Taiwan. It ranks #3749 in the Healthcare sector, and #740 in the Biotechnology industry.
Global Rank
42413
Country Rank
2335
Sector Rank
3749
Industry Rank
740
Key Stats
Market Cap
$8.04MUSD
254.33M TWD
Enterprise Value
$19.25MUSD
609.06M TWD
Revenue (TTM)
$6.95MUSD
219.71M TWD
EBITDA (TTM)
$1.63MUSD
51.67M TWD
Net Income (TTM)
$744.52KUSD
23.54M TWD
EBITDA Margin
24%
Profit Margin
11%
PE Ratio
12.0
PS Ratio
1.2
PB Ratio
0.9
EV/EBITDA
11.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Mingwei Zhuo open_in_new
Employees
52
Founded
1995
Website
rbcbioscience.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.8% 2.1% 29% 17% 10% 21%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
6848
拉法生醫股份有限公司
ISIN: TW0006848005
Shares Out.:
14.273M1
TV:
SA:
YF:
GF:
BA:
MS:
19.45 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About RBC Bioscience Corp.

RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis Taiwan. It offers MagCore Plus II Automated Nucleic Acid Extractor, a robotic bench-top workstation for nucleic acid purification; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore® EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-treatment. The company also provides NGS, genomic DNA, viral nucleic acids, and total RNA kits. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.

Similar Companies

Industry: Biotechnology (Taiwan)
Name
Market Cap diff.
PE
$5.46B
172.76B TWD
68K%
-
$1.61B
50.93B TWD
20K%
-
$1.08B
34.04B TWD
13K%
-
7827
$726.25M
22.97B TWD
9K%
-
7827
$600.25M
18.98B TWD
7K%
-
06891
$571.26M
18.06B TWD
7K%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
2M%
23.9
GILD
$159.92B
2M%
19.0
ARGX
$47.43B
41.39B EUR
590K%
39.9
$44.23B
68.19T KRW
550K%
35.5
CSL
$42.27B
60.27B AUD
526K%
29.3
LONN
$41.88B
33.71B CHF
521K%
37.2
chevron_leftBack